The senolytic field is led by a small number of highly collaborative research groups with overlapping trial participation and co-authorships. The Mayo Clinic (Kirkland/Tchkonia), Scripps Research (Maher), Buck Institute (Campisi), and University of Texas Health (Musi/Gonzales) represent the primary institutional contributors as of 2026.

Which institution runs the most human senolytic trials?

The Mayo Clinic has run more human senolytic trials than any other single institution — including DKD, frailty, IPF, and multiple other disease indications. The University of Texas Health San Antonio has the most Alzheimer's-focused senolytic trials.

How do I access senolytic clinical trial results?

PubMed (pubmed.ncbi.nlm.nih.gov) is the primary database for peer-reviewed results. ClinicalTrials.gov lists ongoing and completed trials with registration data. bioRxiv and medRxiv post preprints before peer review.